Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121608062 | 12160806 | 2 | F | 20141209 | 20160708 | 20160308 | 20160712 | PER | US-CELGENEUS-USA-2016030885 | CELGENE | 81.49 | YR | F | Y | 65.83000 | KG | 20160712 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121608062 | 12160806 | 1 | PS | VIDAZA | AZACITIDINE | 1 | Subcutaneous | 75 MILLIGRAM/SQ. METER | U | U | 50794 | 75 | MG/M**2 | INJECTION | |||||
| 121608062 | 12160806 | 2 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Oral | 0 | 400 | MG | TABLETS | BID | |||||||
| 121608062 | 12160806 | 3 | C | Atorvastatin | ATORVASTATIN | 1 | Oral | 0 | 5 | MG | TABLETS | QD | |||||||
| 121608062 | 12160806 | 4 | C | STOOL SOFTENER | DOCUSATE CALCIUM | 1 | Oral | 0 | 1 | DF | TABLETS | QD | |||||||
| 121608062 | 12160806 | 5 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | Oral | 0 | 100 | MG | CAPSULES | BID | |||||||
| 121608062 | 12160806 | 6 | C | Lactobacillus | LACTOBACILLUS ACIDOPHILUS | 1 | Oral | 0 | 1 | DF | CAPSULES | QD | |||||||
| 121608062 | 12160806 | 7 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 0 | 1 | MG | TABLETS | QD | |||||||
| 121608062 | 12160806 | 8 | C | MYRBETRIQ | MIRABEGRON | 1 | Oral | 800 MILLIGRAM | 0 | 1 | DF | TABLETS | QD | ||||||
| 121608062 | 12160806 | 9 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | 5 MILLIGRAM | 0 | UNKNOWN | |||||||||
| 121608062 | 12160806 | 10 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 121608062 | 12160806 | 11 | C | Probiotic | PROBIOTICS NOS | 1 | Unknown | 1 TABLET | 0 | UNKNOWN | |||||||||
| 121608062 | 12160806 | 12 | C | VIBRAMYCIN | DOXYCYCLINE | 1 | Unknown | 1 CAPSULE | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121608062 | 12160806 | 1 | Myelodysplastic syndrome |
| 121608062 | 12160806 | 2 | Antiviral treatment |
| 121608062 | 12160806 | 3 | Product used for unknown indication |
| 121608062 | 12160806 | 4 | Product used for unknown indication |
| 121608062 | 12160806 | 5 | Product used for unknown indication |
| 121608062 | 12160806 | 6 | Product used for unknown indication |
| 121608062 | 12160806 | 7 | Product used for unknown indication |
| 121608062 | 12160806 | 8 | Product used for unknown indication |
| 121608062 | 12160806 | 9 | Antibiotic prophylaxis |
| 121608062 | 12160806 | 11 | Vitamin supplementation |
| 121608062 | 12160806 | 12 | Antibiotic prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121608062 | 12160806 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121608062 | 12160806 | Neutrophil count decreased | |
| 121608062 | 12160806 | Pancytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121608062 | 12160806 | 1 | 20141117 | 20150123 | 0 | |
| 121608062 | 12160806 | 2 | 20141106 | 20150316 | 0 | |
| 121608062 | 12160806 | 9 | 20141020 | 20150316 | 0 | |
| 121608062 | 12160806 | 10 | 20141209 | 20141219 | 0 | |
| 121608062 | 12160806 | 11 | 20141020 | 20150316 | 0 | |
| 121608062 | 12160806 | 12 | 20141209 | 20141219 | 0 |